Cardiac enzymes after transmyocardial laser treatment with CO2 Laser

Scandinavian Cardiovascular Journal

Volumn 35, Issue 1, 2001, Pages 19-24

  Tjomsland, Ole ^a,c   Aaberge, Lars ^b   Almdahl, Sven M ^a   Moelstad, Per ^a   Rootwelt, Kjell ^b   Nordstrand, Kenneth ^b   Saatvedt, Kjell ^a  

^a Feiring Heart Clinic   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Department of Cardiothoracic Surgery   (Norway)

Author keywords

Adverse events; ASAT; CK mb; Transmyocardial laser treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE MB; HEART ENZYME;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGINA PECTORIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANADA; CARBON DIOXIDE LASER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORRELATION FUNCTION; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENZYME RELEASE; FOLLOW UP; GATED IMAGING; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HEART VENTRICULOGRAPHY; HUMAN; MEDICAL SOCIETY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGINA PECTORIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOENZYMES; LASER SURGERY; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE PERIOD; STROKE VOLUME; TRANSFERASES;

EID: 0035044258     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/140174301750101401     Document Type: Article

References (16)

1. Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998; 31: 241-251.
2. Tjomsland O, Aaberge L, Almdahl SM, et al. Perioperative cardiac function and predictors for adverse events after transmyocardia! laser treatment. Ann Thorac Surg2000;69: 1098-1103.
3. Aaberge L, Nordstrand K, Dragsund M, et al. Transmyocardial revascularization with CUT laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial. J Am Coll Cardiol 2000; 35: 1170-1177.
4. Saatvedt K, Dragsund M, Nordstrand K. Transmyocardial laser revascularization and coronary bypass grafting without cardiopulmonary bypass. Ann Thorac Surg 1996; 62: 323-324.
5. Nomenclature and criteria for diagnosis of ischémie heart disease. Report of (he Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979; 59: 607-609.
6. Burkhoff D, Schmidt S, Schulman SP, et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet 1999; 354: 885-890.
7. Hughes GC, Landolfo CK, Löwe JE, Coleman ER, Donovan CL. Diagnosis, incidence and clinical significance of early postoperative ischemia after transmyocardial laser revascularization. Am Heart J 1999; 137: 1163-1168.
8. Kadipasaoglu KA, Frazier OH. Transmyocardial laser revascularization: effect of laser parameters on tissue ablation and cardiac perfusion. Semin Thorac Cardiovasc Surg 1999; 11:4-11.
9. Whittaker P. Transmyocardial revasculari/ation: the fate of myocardial channels. Ann Thorac Surg 1999; 68: 2376-2382.
10. Fisher PE, Khomoto T, DeRosa CM, Spotnitz HM, Smith CR, Burkhoff D. Histologie analysis of transmyocardial channels: comparison of COj and holniium:YAG lasers. Ann Thorac Surg 1997; 64: 466-472.
11. Tjomsland C), Grund F, Kanellopoulos GK, Kvernebo K, Ilehekk A. Transmyocardial laser induces coronary hyperemia and reduces ischemia-related arrhythmias, but fails to delay development of myocardial necrosis after coronary artery occlusion in pigs. J Cardiovasc Surg 1999; 40: 325-31.
12. Jansen ED, Frenz M, Kadipasaoglu K, et al. Laser-tissue interaction during transmyocardial laser revascularization. Ann.Thorac.Surg. 1997: 63: 640-647.
13. Graeber GM. Snyder RJ. Zajtchuk R, Brott WH. A comparison of serum isoenzyme levels of creatine phosphokinase and lactid dehydrogenase in patients undergoing thoracic operations and patients admitted to a coronary care unit. Ann Thorac Surg 1980; 30: 364-369.
14. Wan S, Izzat MB, Lee TW, Wan IY, Tang NL, Yim AP. Avoiding cardiopulmonary bypass in multivessel CABG reduces eytokine response and myocardial injury. Ann Thorac Surg 1999; 68: 52-56.
15. Ohman EM, Califf RM, Topol EJ. Cardiac troponins in acute coronary syndromes. N Engl J Med 1997; 335: 1257-1259.
16. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993; 88: 750-763.